Repatha 140 MG/ML sureclickml
Ended Awarded Last action
- Contract number
- SPE2DR26F3P3H
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,915
Award facts
- Contract value 100% obligated
- $33,915.03 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at $33,915.03 to Amerisourcebergen Drug Corp for the supply of Repatha 140 mg/ml SureClick autoinjectors. This firm fixed-price, competitively awarded contract carries an ultimate completion date of January 8, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under DLA's larger Indefinite Delivery Contract (IDC) with Cencora, Inc. (Amerisourcebergen's parent company), a $999.99 billion pharmaceutical prime vendor agreement running through December 2031 that provides comprehensive global pharmaceutical support for military healthcare programs.
Amerisourcebergen Drug Corp serves as a critical vendor within the federal pharmaceutical supply chain, specializing in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to support Department of Defense and veteran healthcare systems. The Repatha autoinjector delivery fulfills military medical supply requirements through DLA's Troop Support Medical division, which manages pharmaceutical procurement for military treatment facilities and related federal healthcare institutions. This non-set-aside award reflects the contractor's demonstrated capability to compete on a full and open basis and efficiently fulfill government requirements for essential prescription medications and medical devices.
Quick answers
Who was awarded contract SPE2DR26F3P3H?
SPE2DR26F3P3H was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F3P3H worth?
The government has obligated $33,915 on SPE2DR26F3P3H.
Is contract SPE2DR26F3P3H an order under another contract?
Yes. SPE2DR26F3P3H is a delivery order under SPE2DR25D3008, an indefinite delivery contract.
Was contract SPE2DR26F3P3H competed?
The extent of competition for SPE2DR26F3P3H was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award